[Effectiveness of a structured educative program in Chilean diabetic patients]. / Eficacia de un programa educativo estructurado en población diabética chilena.

BACKGROUND: Structured educative programs have demonstrated their usefulness as a strategy to improve metabolic control in diabetic patients. AIM: To evaluate the effectiveness of a structured educative program for Chilean diabetic patients. MATERIAL AND METHODS: A randomized clinical trial in diabetic patients with glycosylated hemoglobin over 7.5%. One hundred fifteen patients were studied, 59 patients participated in the structured educative program (experimental group) and 56 patients received no structured education (control group). Patients were followed for 12 months. RESULTS: Between baseline and 12 months of follow-up, glycosylated hemoglobin changed from 10.05 to 9.11% in experimental patients and from 9.86 to 9.25% in controls. No significant differences between experimental and control groups in other clinical and metabolic parameters were observed. In the experimental group, glycosylated hemoglobin reductions differed among the different educators who carried out the program. CONCLUSIONS: A structured educative program resulted in a 35% greater reduction in glycosylated hemoglobin levels, compared with a control group. Metabolic control improvement differed between the educators who carried out the program.

Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis.

INTRODUCTION: Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, is associated with high morbidity and mortality. The aim of the current study was to describe the historical and recent epidemiology of IMD in Colombia. METHODS: This retrospective surveillance database analysis examined all available data on IMD in Colombia. Data were extracted from publicly available disease event reports and laboratory surveillance reports or obtained directly from hospitals in Cartagena. RESULTS: During 2015-2021, the overall incidence of IMD was 0.04-0.18 per 100,000 based on laboratory surveillance reports. IMD incidence was highest among infants aged < 1 year (0.52-1.47 per 100,000), as was IMD mortality (0.00-0.65 per 100,000). Serogroup B was the dominant serogroup responsible for IMD in Colombia during 1988-2014, but, since 2015, serogroup C has been dominant in all age groups, followed by serogroups B and Y. During 2010-2021 combined, the majority of IMD cases were reported in Bogotá (31.9%) and Antioquia (21.7%). Of 42 IMD cases in the city of Cartagena, 54.8% occurred in people who lived in the poorest neighborhoods, and these patients had the highest IMD lethality (52.2%) and the shortest median hospitalization duration (3 days). CONCLUSION: The overall incidence of IMD in Colombia was low but was highest among infants aged < 1 year. IMD cases tended to be concentrated in the more densely populated areas and in poorer neighborhoods. As the majority of IMD cases in Colombia since 2015 have been serogroup C, followed by B or Y, vaccination to protect against these serogroups could potentially be beneficial and help to achieve the World Health Organization's and Pan American Health Organization's roadmaps to defeat meningitis by 2030.

Protocol-driven therapy for lower extremity ulcers: a case series supporting the use of porcine intestine extracellular matrix.

INTRODUCTION: Chronic ulcers pose a public health challenge. Thus, it is imperative to be aware of and assess new management strategies that contribute to patient quality of life and optimize health resources. This study evaluated the efficacy of a new protocol for chronic wound management that includes porcine intestine ECM. MATERIALS AND METHODS: Twenty-one patients with chronic wounds of different etiologies were included in this study. A new healing protocol that incorporates the use of porcine ECM was initiated for a maximum period of 12 weeks. Follow-up included a weekly visit to photograph the ulcers and record their size. RESULTS: Wounds ranged in size from 0.5 cm2 to 10 cm2 at the outset of the study. Two of the 21 patients who started the protocol withdrew, 1 for nonadherence to the protocol and 1 for health complications unrelated to the study. Most lesions occurred in the lower limbs. All patients who completed the treatment protocol achieved wound regeneration and total wound closure within an average of 4.5 weeks. The average percentage closure rate was 100% at 8 weeks, with no AEs. CONCLUSIONS: The findings of this study demonstrate the efficacy of an evidence-based wound management protocol in achieving safe, complete tissue regeneration in a short period of time.

Budget impact analysis of pneumococcal conjugate vaccines in Colombia.

Objective: Pneumococcal diseases including invasive pneumococcal disease (IPD), pneumonia, and acute otitis media (AOM) impose a substantial public health burden. This study performed a budget impact analysis of the use of pneumococcal conjugate vaccines (PCVs) in the National Immunization Program (NIP) in Colombia.Methods: We compared the direct medical cost of the scenario without and with PCV vaccination using either pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or 13-valent pneumococcal conjugate vaccine (PCV-13) over 5 years (2020-2024) from the health-care system perspective. Vaccine efficacy estimates were obtained from published sources and vaccine prices were taken from the Pan-American Health Organization Revolving Fund. Vaccine coverage was assumed to be 90% based on Colombia data.Results: Using PHiD-CV in the NIP in Colombia would reduce the estimated cost for treating pneumococcal disease by US$46.1 m over the 2020-2024 period (US$40.2 m using PCV-13), with a budget impact of US$100.1 m for PHiD-CV (US$121.4 m for PCV-13), and would cost US$3.1 m less per year on vaccine doses than using PCV-13.Conclusion: These findings are potentially valuable for the selection of vaccines for their national immunization programs under conditions of budgetary constraint.

Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia.

In Colombia, pneumococcal conjugate vaccines (PCVs) were implemented into the infant universal mass vaccination program in a stepwise manner; PCV-7 between 2009 and 2011 in different geographic regions/cities, with nationwide introduction of a 10-valent vaccine (PHiD-CV) in 2012. We aimed to describe trends in all-cause pneumonia mortality and overall mortality, and in the incidence of all-cause pneumonia and otitis media (OM) in Colombian children <2 y (y = years) of age, before and after PCV introduction. We obtained mortality and incidence data, nationally and for five major cities (Bogota, Medellin, Barranquilla, Cali and Cartagena) from 2005-2016 and 2008-2016, respectively, comparing mortality and incidence proportions in the post-PCV introduction period with those in the pre-PCV period. Overall mean reductions in all-cause pneumonia mortality was observed in the post-PCV period nationally (48.8%; 95%CI: 45.5-51.8%) and in four cities including Bogota (77.1%; 71.1-81.8%) and Medellin (56.4%; 44.1-65.9%); no substantial reduction was observed in Cartagena. Similar findings were observed for overall mortality. Reductions in all-cause pneumonia incidence were observed in Bogota (66.0%; 65.5-66.6%), Medellin (40.6%; 39.3-41.9%) and Cartagena (15.0%; 11.2-18.6%), while incidence increased in Barranquilla (78.5%; 68.4-89.2%) and Cali (125.5%; 119.2-132.0%). All-cause OM incidence fell in Medellin and Bogota (42.1-51.1%) but increased (95.8%) in Barranquilla. In conclusion, overall reductions in disease outcomes were observed following PCV introduction in most cities and nationwide. Decreasing trends in outcomes were observed prior to PCV introduction, and limited data points and data reporting issues may have influenced our results. (ClinicalTrials.gov: NCT02567747).

Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogotá, Colombia.

BACKGROUND: Maternal immunization with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine confers protection to young infants. We aimed to describe trends in pertussis incidence and associated mortality in children aged <12 months before and after introduction of maternal Tdap immunization in Bogotá, Colombia. METHODS: Data on pertussis-related cases/deaths in infants aged <12 months were collected from SIVIGILA for the period 2005-2016, and compared incidence for the pre-vaccine introduction (2005-2012) and post-maternal Tdap vaccination (2014-2016) periods in infants aged <12 months and in three distinct age-strata; ≤6 weeks, 7-<28 weeks, and 28-52 weeks. Mortality comparisons were performed in all infants <12 months. RESULTS: From 2005 to 2016, 2315 laboratory or clinically-confirmed pertussis cases were reported in infants <12 months of age (278 cases in young infants aged ≤6 weeks); 55 pertussis deaths were reported in children aged <12 months. No pertussis deaths were reported in the 2014-2016 period. Since maternal Tdap introduction in 2013, a consistent decline in pertussis incidence and mortality was observed. In the time-series analysis, incidence declined from 209.4/100,000 persons (2005-2012) to 49.1/100,000 persons (2014-2016) in all children <12 months; a 87.5% (95%CI: 77.2-93.2%) reduction. For these same period's incidence in young infants ≤6 weeks declined from 196.7 to 89.6/100,000 person-years (an 54.4% [95% CI: 35.4-67.9%] reduction). Greater incidence reductions were observed in older infants; 73.4% (95% CI: 68.4-77.6%) in those aged 7-<28 weeks, and 100% in those aged 28-52 weeks. A 100% reduction in Pertussis mortality in infants <12 months was observed. Since Tdap introduction, maternal vaccine coverage rose from <60% in 2013-2015 to 80% in 2016. CONCLUSIONS: Implementation of maternal immunization in Bogotá may have contributed to the reduction in pertussis incidence and mortality among infants <12 months of age (ClinicalTrials.gov: NCT02569879). An Audio Summary linked to this article that can be found on Figshare https://doi.org/10.6084/m9.figshare.12943316.

Estimated Annual Health and Cost Impact of PHiD-CV Immunization Program in Brazil.

BACKGROUND: Streptococcus pneumoniae causes invasive pneumococcal disease (IPD), community-acquired pneumonia (CAP) and acute otitis media (AOM). Two higher-valent pneumococcal conjugate vaccines (PCV) are available, pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) and 13-valent PCV (PCV-13). This study estimated the economic and health impact of PHiD-CV vaccination on pneumococcal disease burden in children <5 years of age in Brazil. METHODS: The disease burden prior to the PHiD-CV vaccination program was estimated from literature and databases. The effect of PHiD-CV was estimated as a reduction of 70% for IPD, 26% for CAP and 40% for AOM, based on published studies. Residual IPD cases attributable to serotype 19A were estimated using surveillance data. PCV-13 effectiveness against 19A-IPD was set at 30%-70% higher than PHiD-CV. Vaccine prices were US$12.85/dose for PHiD-CV and US$14.50/dose for PCV-13. RESULTS: PHiD-CV vaccination reduced IPD by 6359, CAP by 315,016 and AOM by 669,943 cases, with estimated cost savings of >US$84 million annually and US$211-22,232 per case averted depending on the outcome. Switching from PHiD-CV to PCV-13 would avoid only a few additional IPD cases at additional costs exceeding US$18 million per year (US$125,192-386,230 per IPD case averted). CONCLUSIONS: The PHiD-CV vaccination program in Brazil has resulted in important reductions of pneumococcal disease and substantial cost savings. Instead of switching PCVs, expanding vaccine coverage or investing in other health care interventions would be a more efficient use of resources to improve the health of the population in Brazil.

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis.

Colombia introduced mass pneumococcal conjugate vaccination at the end of 2011. Using 2005-2015 surveillance data, we conducted a retrospective interrupted time-series analysis. A significant trend towards reduced monthly was observed in the post-vaccination period (2012-2015) compared with the expected rate, reaching in 2015 a reduction of 90.5% of pneumococcal meningitis. This trend was not observed for control diseases.

Análisis de Costos de cuidados en salud para pacientes con cáncer al final de la vida: Hospital versus domicilio con cuidados paliativos, en el tercer nivel de atención / Analysis of health care costs for patients with cancer at the end of life: Hospital versus home with palliative care, at the third level of care

Introducción: La etapa final de pacientes oncológicos genera elevados costos, sobretodo en hospitales. Objetivos: Determinar la diferencia de costos de atención al final de la vida de pacientes oncológicos en el hospital versus el domicilio. Material y métodos: Estudio retrospectivo de análisis de costos en pacientes fallecidos por cáncer en estadio clínico IV de un hospital terciario de la seguridad social, marzo 2018. Se comparó un grupo domiciliario (GD) de un programa paliativo con un grupo hospitalario (GH) admitido por emergencia. Se estimaron costos directos de servicios profesionales, hospitalización, procedimientos, exámenes auxiliares y medicamentos. Para el análisis estadístico se utilizó Chi cuadrado y T de Student, considerando un valor p<0,05 y utilizando SPSS 24.0. Resultados: Se incluyeron 81 pacientes en GD y 22 en GH, edad entre 36 y 96 años, con una mediana de 72 años en GD y 77 en GH (p=0,97), sexo femenino 59 y 73% respectivamente (p=0,25), predominando cáncer de origen digestivo y genitourinario. El costo promedio por paciente en GD fue 497 dólares americanos y en el GH 1908 (p<0,01), con un promedio diario por pacientes de 17 vs 447 respectivamente. En el GH predominaron los costos de hospitalización, exámenes auxiliares (tomografía, resonancia, análisis de gases arteriales, proteína C reactiva) y antibióticos (ertapenem y colistina), mientras que en GD el mayor costo fue en servicio médicos y medicamentos. Conclusión: Los costos médicos en la etapa final de vida de pacientes con cáncer avanzado son 3,8 veces mayor cuando fallece en el hospital que en el domicilio.

Background: The final stage of cancer patients generates high costs, especially in hospitals. To determine the difference in care costs Objectives:at the end of life for cancer patients in the hospital versus at home. Material and methods: Retrospective cost analysis study in patients who died of clinical stage IV cancer in a tertiary social security hospital, March 2018. Ahome group (Home) of a palliative program was compared with a hospital group (Hospital) admitted from the emergency department. Direct costs of professionalservices,hospitalization,procedures,auxiliaryexams,and medications were estimated. Chi square and Student's Twere used for statistical analysis, considering a value of p<0.05 and using SPSS 24.0. Results: 81 patients in Home and 22 in Hospital were included, aged between 36 and 96 years, with a median of 72 years in Home and 77 in Hospital (p=0.97), female sex 59 and 73% respectively (p= 0.25), predominantly cancer of digestive and genitourinary origin. The average cost per patient in Home was 497 US dollars and in Hospital 1908 (p<0.01), with a daily average per patient of 17 vs 447 respectively. In the Hospital, the costs of hospitalization, auxiliary tests (tomography, resonance, arterial gas analysis, C-reactive protein) and antibiotics (ertapenem and colistin) predominated, while in the Home the highest cost was in medical services and medications. Conclusion: The medical costs in the final stage of life of patients with advanced cancer are 3.8 times higher when they die in the hospital than at home.

[Epidemiologic profile of the population displaced by the internal armed conflict of the country in a neighborhood of Cartagena, Colombia, 2000]. / Perfil epidemiológico de la población desplazada por el conflicto armado interno del país en un barrio de Cartagena, Colombia, 2000.

Colombia faces internal displacement as a consequence of internal armed conflict. From 1985 to the present, it is estimated that 1,500,000 people have been displaced. A transversal descriptive study aimed at characterizing the health situation of this highly vulnerable and continually growing population was carried out in Cartagena between September and December, 2000. The sample size was calculated to meet a 2% precision, 40% of maximum expected prevalence, design effect of 2 and 15% of information loss, total sample size 1.600 home's interviews. Single-stage sampling with replacement was done by clusters. To socioeconomic, sanitary conditions, morbidity and mental health variables was done univariate analysis, determining frequencies, central trend and dispersion, as well as a bivariate analysis to determine X2 or Fisher exact test, p values and stratified analysis. The study found severe deterioration in socioeconomic conditions, high exposure to violence (80% was exposed to violence before displacement and murder cause 60% of deads in teenagers and adults after displacement but even children under 4 years-old was affected by this phenomenon), family disintegration, bad sanitary conditions, high prevalence of tracing diseases in all ages (80% of under 5 years-old had respiratory symptoms, 30% diarrhoea and 32% purulent lesions in skin), school desertion (20% children between 5 and 11 years and 16% teenagers), late schooling, poor performance at school, high proportion of working children (4% children between 5 and 11 years and 20% teenagers), low affiliation to social security systems (only 20% under 5 years-old children and 50% adults), low coverage and access to health services, among many other factors whose interaction affects this population's physical and mental health. We found that is difficult to make an early detection of internally displaced populations and thus provide adequate health care when such displacements are recent or involve individual persons. Results show that is essential to implement a surveillance system based on community leaders to increase efficiency, access and opportunity in health care for displaced populations.

[Risk factors for severe acute lower respiratory tract infection in Bogota, 2001]. / Factores de riesgo para infección respiratoria aguda baja grave en Bogotá, 2001.

Severity of acute respiratory infection is higher in developing countries, especially among the socioeconomically underprivileged. Viral pneumonias are more common, especially among children. A prospective hospital-based case control study was undertaken in Bogota between November 2000 and August 2001, aimed to identify factors related to severe low acute respiratory infection (SLARI). Cases were limited to children aged between 2 months and 5 years who filled WHO criteria for SLARI. Controls were children at the same hospital with ARI in a similar age range, but without symptoms of chest drawing. A total of 638 children (277 cases and 361 controls) were included. The most important risk factors included the following: living in borrowed houses (odds ratio (OR) = 2.7; 95% Confidence Interval (CI): 1.06-7.07), sharing the bed (OR = 1.88, CI: 1.0-3.7), living with more than 9 people (OR = 1.82, CI: 1.0-3.51), and living with smokers (OR = 1.4, CI: 1.0-2.05). Of the 114 samples collected (from children at third day after beginning of symptoms), 98 had viruses, sincitial respiratory virus was the most frequently identified virus (41.8%), followed by influenza A virus (3.1%) and influenza B virus (1%). All positive isolates for influenza A and B were sent to the United States Center for Disease Control (CDC) in Atlanta, where they were classified as influenza A/PANAMA/2007/99-like and influenza B/SICHUAN/379/99-like, respectively.

[Variability in bioelectrical impedance assessment of body composition depending on measurement conditions: influence of fast and rest]. / Variabilidad de la composición corporal medida con bioimpedanciometría eléctrica según condiciones de realización: influencia del ayuno y del reposo.

BACKGROUND: Bioelectrical Impedance Assessment (BIA) is one of the main tools to measure body composition. BIA is recommended in fasting and after 60 minutes of rest; however, this cannot always be guaranteed in healthcare practice. OBJECTIVES: To establish the reliability of the body composition parameters assessed with BIA under different physiological conditions: fast + rest, fast + no-rest and no-fast + no-rest in healthy volunteers. METHODS: Transversal study including 25 healthy volunteers aged 18-34 (12 men, 13 women). A BIA was performed under three different conditions: 1) fast + 60 minute rest in cubito supino (gold standard), 2) fast + no rest and 3) no fast + no rest. The collected parameters were: lean mass and fat mass (Kg) and body water (in liters and as body weight percentage). The intraclass correlation coefficient (ICC) was applied for the assessment of concordance within the different measurements. RESULTS: Compared to the gold standard, the difference in lean mass means in the condition of fast + no-rest, was -0.15 (DE 1.44) in men and 0.98 (DE 1.36) in women; fat mass decreased in 0.06 (DE 1.55) in men and 0.82 (DE 1.5) in women; ICC ranged between 0.826-0.995 in all comparisons. In the condition of no-fast + no rest, lean mass decreased an average of 0.05 (DE 0.33) in men and it increased 0.62 (DE 0.46) in women; fat mass decreased 0.57 (DE 0.82) in men and 0.46 (DE 0.60) in women; ad ICC ranged between 0.942 and 0.999, except in body water in men, where it was 0.340. DISCUSSION: Although relevant, the differences observed in parameters from BIA when comparing the gold standard condition (fast + rest) with the other conditions (fast + no-rest and no-fast + no-rest) are of little magnitude. In clinical practice, the assessment of body composition allows to take decisions when planning treatment for patients with a poor physical condition. CONCLUSIONS: The reliability of the parameters acquired via BIA within different physiological conditions of fast and rest is excellent (CCI >0.75) in healthy adults aged 19-34. Although general recommendations on the use of BIA devices must be kept in place, the conditions of the performance could be modified according to the context and assuming a small difference of little clinical relevance.

Introducción: La bioimpedanciometría eléctrica (BIA) constituye una de las principales herramientas para evaluar la composición corporal. Aunque se recomienda la realización de la BIA en condiciones de ayuno y 60 minutos de reposo, en la práctica asistencial no siempre es posible garantizar su cumplimiento. Objetivos: Determinar la fiabilidad de los parámetros de composición corporal estimados por BIA bajo diferentes condiciones fisiológicas: ayuno + reposo, ayuno + no-reposo y no-ayuno + no- reposo en voluntarios sanos. Metodología: Estudio transversal en 25 voluntarios sanos entre 18 y 34 años de edad (12 hombres, 13 mujeres). Se realizó una BIA en tres condiciones diferentes: 1) ayuno + reposo de 60 minutos en decúbito supino (gold standard), 2) ayuno + no reposo y 3) no ayuno + no reposo. Los parámetros recogidos fueron: masa magra y masa grasa (Kg) y agua corporal (litros y en porcentaje del peso corporal). Para valorar la concordancia entre las diferentes mediciones, se utilizó el coeficiente de correlación intraclase (CCI). Resultados: En comparación con el gold standard, la diferencia de medias de la masa magra en la condición de ayuno + no-reposo, fue -0.15 (DE 1.44) en los hombres y 0.98 (DE 1.36) en mujeres; la masa grasa disminuyó 0.06 (DE 1.55) en hombres y 0.82 (DE 1.5) en mujeres; el CCI osciló entre 0.826-0.995 en todas las comparaciones. En la condición de no-ayuno + no reposo, la masa magra disminuyó una media 0.05 (DE 0.33) en los hombres y en las mujeres se incrementó 0.62 (DE 0.46); la masa grasa disminuyó 0.57 (DE 0.82) en hombres y 0.46 (DE 0.60) en mujeres; y el CCI osciló entre 0.942 y 0.999, excepto en el agua corporal en hombres que fue de 0.340. Discusión: Las diferencias observadas en los parámetros obtenidos por BIA al comparar la condición gold standard (ayuno + reposo) con las otras condiciones (ayuno + no reposo y no-ayuno + no-reposo), aunque significativas, son de escasa magnitud. En la práctica clínica, la valoración de parámetros de composición corporal permite tomar decisiones a la hora de planificar el tratamiento en pacientes con desacondicionamiento físico. Conclusiones: La fiabilidad de los parámetros obtenidos por BIA entre diferentes condiciones fisiológicas de ayuno y reposo es excelente (CCI >0.75) en adultos sanos entre 19 y 34 años. Si bien las recomendaciones generales sobre el uso de los dispositivos de BIA se deben mantener, las condiciones de realización podrían modificarse en función del contexto asumiendo una diferencia de pequeña magnitud y escasa relevancia clínica.

Eficacia de un programa educativo estructurado en población diabética chilena / Effectiveness of a structured educative program in Chilean diabetic patients

Background: Structured educative programs have demonstrated their usefulness as a strategy to improve metabolic control in diabetic patients. Aim: To evaluate the effectiveness of a structured educative program for Chilean diabetic patients. Material and Methods: A randomized clinical trial in diabetic patients with glycosylated hemoglobin over 7.5%. One hundred fifteen patients were studied, 59 patients participated in the structured educative program (experimental group) and 56 patients received no structured education (control group). Patients were followed for 12 months. Results: Between baseline and 12 months of follow-up, glycosylated hemoglobin changed from 10.05 to 9.11% in experimental patients and from 9.86 to 9.25% in controls. No significant differences between experimental and control groups in other clinical and metabolic parameters were observed. In the experimental group, glycosylated hemoglobin reductions differed among the different educators who carried out the program. Conclusions: A structured educative program resulted in a 35% greater reduction in glycosylated hemoglobin levels, compared with a control group. Metabolic control improvement differed between the educators who carried out the program.

Disfunción muscular respiratoria en pacientes llevados a cirugía cardiovascular / Respiratory muscle dysfunction in patients undergoing cardiovascular surgery

Resumen Objetivo: Evaluar la presencia de las alteraciones en la fuerza muscular respiratoria en pacientes programados para la cirugía cardiovascular, el impacto de la cirugía sobre la función muscular respiratoria y su relación con las alteraciones ventilatorias en el postoperatorio mediato. Métodos: Estudio observacional prospectivo. Se realizaron pruebas de funcionalismo respiratorio (espirometría) y pruebas de fuerza muscular respiratoria (inspiratoria: presión inspiratoria máxima y espiratoria: presión espiratoria máxima) en dos momentos: preoperatorio inmediato (2 ± 1 días precirugía) y postoperatorio mediato (2 ± 1 días, antes del alta). Las complicaciones respiratorias incluyeron: la ventilación mecánica prolongada, el tromboembolismo pulmonar, el neumotórax, el hemotórax, la neumonía, el derrame pleural, el edema pulmonar y las atelectasias. Resultados: Se evaluaron 30 pacientes adultos (n = 30) (62 ± 12 años). En el preoperatorio la capacidad espirométrica disminuyó en un 54% (35% alteración obstructiva, 19% no- obstructiva) y la debilidad inspiratoria y espiratoria fue confirmada en un 67 y 100%, respectivamente. Las complicaciones respiratorias estuvieron presentes en un 93% (con mayor frecuencia la atelectasia y el derrame pleural). El deterioro postoperatorio grave de la presión inspiratoria máxima incrementó 10 veces el riesgo de atelectasia (OR = 10, IC 95% 0,85-117,02; p = 0,067). Al alta, la fracción de eyección del ventrículo izquierdo fue 29% menor, la capacidad vital forzada -32%, la presión inspiratoria máxima -32% y la presión espiratoria máxima -32% con respecto al valor inicial. Conclusiones: Los pacientes llevados a la cirugía cardiovascular tienen una insospechada disfunción de los músculos respiratorios que empeora con la cirugía y la hospitalización, que se asocia a un incremento del riesgo de complicaciones respiratorias.

Abstract Motivation: To assess the presence of alterations in respiratory muscle strength in patients with a programmed cardiovascular surgery, the impact of the surgery on respiratory muscle function and their relationship with ventilatory alterations during mediate postoperative period. Methods: Prospective observational study. Respiratory function tests (spirometry) and respiratory muscle strength tests (inspiratory: maximum inspiratory pressure, and expiratory: maximum expiratory pressure) were conducted in two moments: immediate preoperative (2 ± 1 days before surgery) and mediate postoperative period (2 ± 1, before being discharged). Respiratory complications included prolonged mechanical ventilation, pulmonary thromboembolism, pneumothorax, hemothorax; pneumonia; pleural effusion; pulmonary edema and atelectases. Results: 30 adult patients were assessed (n = 30) (ages 62 ± 12). Spirometry performance decreased by 54% in the preoperative period (35% obstructive alteration, 19% non-obstructive) and inspiratory and expiratory weakness was confirmed at 67 and 100% respectively. Respiratory complications were present in 93% (more frequently atelectasis and pleural effusion). Severe postoperative deterioration of maximum inspiratory pressure increased by 10-fold the risk of atelectasis (OR = 10, IC 95% 0.85-117.02; p = 0.067). Upon discharge, ejection fraction of the left ventricle was 29% lower, forced vital capacity -32%, maximum inspiratory pressure -32% and maximum expiratory pressure -32% with regards to baseline values. Conclusion: Patients undergoing cardiovascular surgery suffer an unsuspected respiratory muscle dysfunction that worsens with surgery and hospitalisation, associated to a increase of the risk of respiratory complications.

TriBURTER: invención y validación perceptual del dispositivo portátil de vibración de alta frecuencia y entrenamiento muscular para pacientes con enfermedades respiratorias / TriBURTER: invention and perceptual validation of a portable device aimed to induce high- frequency vibration and respiratory muscle training in patients with respiratory diseases

Introducción: los dispositivos respiratorios vibrátiles son útiles como elementos de terapia respiratoria pues facilitan la expectoración de las secreciones bronquiales. Un dispositivo respiratorio de vibración que incorpore válvulas duales representa una innovación relevante respecto a los modelos existentes. El presente estudio describe la invención y evaluación de un nuevo dispositivo médico portátil de vibración de alta frecuencia para uso humano que permite simultáneamente el entrenamiento muscular respiratorio para pacientes con enfermedades respiratorias, al que se ha denominado con el acrónimo TriBURTER. Métodos: se conceptualizaron, diseñaron y construyeron modelos virtuales y prototipos funcionales siguiendo metodología de bioingeniería y evaluación in situ del funcionamiento a través de simuladores electrónicos. Adicionalmente se evaluaron, mediante escalas psicométricas específicas, los aspectos perceptuales de la morfología y funcionamiento del dispositivo tanto en voluntarios sanos como pacientes. Resultados: se creó un dispositivo que logra tres efectos: facilitar la movilización de secreciones bronquiales, inducir efecto de entrenamiento sobre los músculos inspiratorios, e inducir entrenamiento de músculos espiratorios. La evaluación perceptual demostró que el diseño final del dispositivo es seguro, adecuado, suficiente y práctico. Conclusión: TriBURTER es un dispositivo médico innovador de terapia respiratoria vibrátil que facilita el drenaje de secreciones y genera una sobrecarga muscular, tanto inspiratoria como espiratoria, regulable y útil en el tratamiento de las enfermedades respiratorias, y que puede ser aplicado tanto en ámbito ambulatorio como domiciliario u hospitalario. Su evaluación perceptual demostró seguridad clínica y una adecuada aceptación de uso por parte de los voluntarios sanos y pacientes en términos de cualidad y funcionamiento. MÉD.UIS. 2016;29(2):49-57.

Introduction: vibratory devices are used in respiratory therapy in order to facilitate removal of bronchial secretions. A portable hydraulic system incorporating inspiratory and expiratory valves could provide additional advantages over existing ones. The present study describes the invention and evaluation of a new portable medical device able to induce high frequency vibration and allowing respiratory muscle training for patients with respiratory diseases, which has been named with the acronym TriBURTER. Methods: based on conventional methods of bioengineering, a hydraulic device was conceptualized, designed, built, and validated using electronic simulators. In addition, perceptual evaluations of morphology, final prototype design and function were evaluated in both healthy volunteers and patients through specific psychometric scales. Results: a hydraulic device including two unidirectional valves was finally obtained allowing to induce simultaneously a triple effect: mobilization of bronchial secretions, inspiratory muscle training, and expiratory muscle training. Perceptual evaluations showed that the final design is safe, adequate, sufficient and practical. Conclusion: TriBURTER is an innovative hydraulic medical device for respiratory therapy that facilitates drainage of secretions and generates adjustable inspiratory and expiratory muscle loads. The perceptual evaluations of the device showed proper acceptance of use by healthy volunteers and patients in terms of quality and performance. This device is useful for the treatment of respiratory diseases and can be prescribed for both outpatient and domiciliary or hospital settings. MÉD.UIS. 2016;29(2):49-57.

[Burden of rotavirus-related disease among children under five, Colombia, 2004]. / La carga de la enfermedad por rotavirus en niños menores de cinco años, Colombia, 2004.

OBJECTIVES: To establish an in-hospital surveillance system for diarrhea in children under five, to estimate the burden of rotavirus-related disease, and to identify the most common rotavirus genotypes. METHODS: Included in the study were children who were hospitalized for serious complications of diarrhea in three medical care facilities in Bogotá, Barranquilla, and Cali, Colombia. A solid-phase enzyme-linked immunosorbent assay (ELISA) was used to detect rotavirus, and reverse-transcriptase polymerase chain reaction (RT-PCR) was the genotyping method employed. The frequencies, central tendency, and dispersion of the variables were determined. Stratified analysis and bivariate analysis were performed by applying a chi squared test or Fisher's exact test, or a chi squared test for trends, depending on the type of data analyzed. Relative risks were established. For analyzing trends we performed linear regression and calculated correlation coefficients and P values. RESULTS: Between December 2003 and November 2004, 893 children were hospitalized in the three participating centers included in the study. Of these children, 68% were between 6 and 23 months of age; 2.7% of hospitalized patients showed clinical signs of hypovolemic shock, and 1.2% died. Only 57% of the mothers had given their children an oral rehydration solution before hospitalization. Rotavirus infection was the cause of 50% of hospitalizations (correlation coefficient [r] > 0.8) and was linked to an inability to hold down orally-ingested fluids (relative risk [RR] = 1.45; 95% confidence interval [95% CI]: 1.24 to 1.69; P < 0.0000) and to intractable vomiting (RR = 1.47; 95% CI: 1.16 to 1.86; P < 0.01). Rotavirus infection led to one death per 2 000 children; 16 hospitalizations per 1 000 children, and 631 medical visits per 1 000 children. A seasonal trend was noted for G1P[8], G2P[4], and G3P[8] rotavirus genotypes, and this did not vary as a result of geographic distance or differences in temperature, humidity, and rainfall among cities. CONCLUSIONS: Rotavirus infection is an important cause of morbidity and mortality from diarrhea, particularly during the first years of life, when children are more susceptible to serious complications. It is important for prevention strategies to have a high impact before 6 months of age, and vaccination against rotavirus can be a good complementary intervention strategy. No description was found in the international scientific literature of the seasonal variations in rotavirus genotypes. It is important to carry out cost-effectiveness studies in order to promote the investment of resources in accordance with population needs, and to continue surveillance activities so as to better understand how the virus behaves.

[Acute diarrheal disease: a public health challenge in Colombia]. / La enfermedad diarreica aguda: un reto para la salud pública en Colombia.

OBJECTIVES: To establish the relationship between rotavirus infection and dehydration from diarrhea in Colombian children under 5 years of age, and to identify risk factors for diarrhea with dehydration. METHODS: A case-control study was performed in an urban hospital in Bogota, Colombia, between April 2000 and February 2001. The sample was composed of 290 children of both sexes under 5 years of age; of these children, 145 of them were hospitalized for acute diarrheal disease (ADD) with dehydration (cases), and 145 had a diagnosis of ADD but no signs of dehydration (controls). All children underwent a complete physical examination. Mothers responded to a questionnaire containing items on demographic and socioeconomic variables, as well as on knowledge, attitudes, and practices with regard to hygiene, and on access to health services. RESULTS: An association was detected between diarrhea with dehydration and the presence of rotavirus in fecal samples (odds ratio [OR] = 3.46; 95% confidence interval [95% CI]: 1.71 to 7.00), birth weight < 2 600 g (OR = 7.79; 95% CI: 3.47 to 18.01), and breastfeeding for less than 3 months (OR = 3.17; 95% CI: 1.66 to 6.13). The risk of having dehydration was associated with low socioeconomic status, poor hygienic practices among the child's family members, and mother's low educational level. CONCLUSIONS: The ineffectiveness of health promotion and disease prevention activities in a population with easy access to health services set the stage for the appearance of cases of diarrhea with dehydration. Rotavirus infection plays an important role in the severity of ADD among Colombian children.

La carga de la enfermedad por rotavirus en niños menores de cinco años, Colombia, 2004 / Burden of rotavirus-related disease among children under five, Colombia, 2004

OBJETIVOS: Establecer un sistema de vigilancia intrahospitalaria de la diarrea en niños menores de 5 años, estimar la carga de la enfermedad por rotavirus e identificar los genotipos más frecuentes de rotavirus. MÉTODOS: Se incluyó en este estudio a niños hospitalizados por complicaciones graves de la diarrea en tres centros asistenciales de Santa Fe de Bogotá, Barranquilla y Cali, Colombia. Se utilizó un método de enzimoinmunoanálisis en fase sólida (ELISA) para la detección de rotavirus y un método de reacción en cadena de la polimerasa con transcripción inversa (RT-PCR) para la genotipificación. Se determinaron las frecuencias, la tendencia central y la dispersión de las variables. Se realizó un análisis estratificado y un análisis con dos variables, mediante una prueba de la ji2 o una prueba exacta de Fisher, o una prueba de la ji2 para evaluar la tendencia, según los datos. Se establecieron los riesgos relativos. Para el análisis de la tendencia, se utilizaron la regresión lineal, los coeficientes de correlación y los valores de P. RESULTADOS: Entre diciembre de 2003 y noviembre de 2004 se hospitalizó a 893 niños en los tres centros participantes en el estudio, de los cuales el 68 por ciento tenía entre 6 y 23 meses de edad. Un 2,7 por ciento de los pacientes ingresados presentaba un cuadro de choque hipovolémico y un 1,2 por ciento falleció. Solo un 57 por ciento de las madres había administrado a sus hijos una solución de rehidratación oral antes de la hospitalización. La infección por rotavirus motivó un 50 por ciento de las hospitalizaciones (coeficiente de correlación [r] > 0,8) y se relacionó con intolerancia a la vía oral (riesgo relativo [RR] = 1,45; intervalo de confianza del 95 por ciento [IC95 por ciento]: 1,24 - 1,69; P < 0,0000) y vómito incoercible (RR = 1,47; IC95 por ciento: 1,16 - 1,86; P < 0,01). La infección por rotavirus ocasionó una muerte por cada 2 000 niños; 16 hospitalizaciones por cada 1 000 niños y 631 consultas por cada 1 000 niños. Se identificó estacionalidad en los genotipos G1P[8], G2P[4] y G3P[8] de rotavirus, que no varió a pesar de la distancia geográfica y las diferencias de temperatura, humedad y precipitación entre las tres ciudades.CONCLUSIONES: La infección por rotavirus es una causa importante de morbilidad y mortalidad por diarrea, especialmente en los primeros años de vida, cuando los niños están más expuestos a las complicaciones graves. Es necesario que las estrategias de prevención tengan un alto impacto antes de los 6 meses de edad. La vacunación contra el rotavirus puede ser una buena estrategia complementaria de intervención. No se encontró en la literatura internacional ninguna descripción anterior de la estacionalidad de los genotipos de rotavirus. Es importante hacer estudios de costo-efectividad para favorecer la inversión de recursos según las necesidades de la población y continuar la vigilancia para ampliar el conocimiento del comportamiento de este virus.

OBJECTIVES: To establish an in-hospital surveillance system for diarrhea in children under five, to estimate the burden of rotavirus-related disease, and to identify the most common rotavirus genotypes. METHODS: Included in the study were children who were hospitalized for serious complications of diarrhea in three medical care facilities in Bogotá, Barranquilla, and Cali, Colombia. A solid-phase enzyme-linked immunosorbent assay (ELISA) was used to detect rotavirus, and reverse-transcriptase polymerase chain reaction (RT-PCR) was the genotyping method employed. The frequencies, central tendency, and dispersion of the variables were determined. Stratified analysis and bivariate analysis were performed by applying a chi squared test or Fisher's exact test, or a chi squared test for trends, depending on the type of data analyzed. Relative risks were established. For analyzing trends we performed linear regression and calculated correlation coefficients and P values. RESULTS: Between December 2003 and November 2004, 893 children were hospitalized in the three participating centers included in the study. Of these children, 68 percent were between 6 and 23 months of age; 2.7 percent of hospitalized patients showed clinical signs of hypovolemic shock, and 1.2 percent died. Only 57 percent of the mothers had given their children an oral rehydration solution before hospitalization. Rotavirus infection was the cause of 50 percent of hospitalizations (correlation coefficient [r] > 0.8) and was linked to an inability to hold down orally-ingested fluids (relative risk [RR] = 1.45; 95 percent confidence interval [95 percent CI]: 1.24 to 1.69; P < 0.0000) and to intractable vomiting (RR = 1.47; 95 percent CI: 1.16 to 1.86; P < 0.01). Rotavirus infection led to one death per 2 000 children; 16 hospitalizations per 1 000 children, and 631 medical visits per 1 000 children. A seasonal trend was noted for G1P[8], G2P[4], and G3P[8] rotavirus genotypes, and this did not vary as a result of geographic distance or differences in temperature, humidity, and rainfall among cities.CONCLUSIONS: Rotavirus infection is an important cause of morbidity and mortality from diarrhea, particularly during the first years of life, when children are more susceptible to serious complications. It is important for prevention strategies to have a high impact before 6 months of age, and vaccination against rotavirus can be a good complementary intervention strategy. No description was found in the international scientific literature of the seasonal variations in rotavirus genotypes. It is important to carry out cost-effectiveness studies in order to promote the investment of resources in accordance with population needs, and to continue surveillance activities so as to better understand how the virus behaves.